Project Grant 2035639
Award Date
2/15/21
Completion Date
1/31/22
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Potomac, MD 20850, USA
Similar Awards
This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II Cooperative Agreement award to Silvec Biologics Inc. provides $994,939 in funding to develop novel RNA therapies to immunize grapevines, citrus trees, and other agricultural crops against deadly bacteria, fungi, and viruses. The key objectives are to: (1) optimize small interfering RNAs (siRNAs) against the Xylella fastidiosa bacterium that causes olive quick decline syndrome, Pierce's disease in grapes,...
Treeco Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The award funds research to develop genome editing techniques for loblolly pine that can enable more sustainable fiber production in the southern United States. Specifically, the one-year project will apply new biotechnologies to loblolly pine to improve traits such as disease resistance and fiber yield. By enhancing...
Biotech Naturale Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041) for the period of August 1, 2021 through July 31, 2022. The grant funds the development of a simple, targeted, and flexible method for transferring value-added genes from wild relatives of crop plants. The Engineering program seeks to improve quality of life and economic strength through fostering innovation...
This Project Grant award from the National Science Foundation's (NSF) Biological Sciences program provides $500,000 from March 2024 through February 2027 to researchers at the University of Maryland and Silvec Biologics, Inc. to develop methods to stabilize RNA genomes in viruses that can be used as therapies to treat plant diseases. The project aims to use computational approaches, including artificial intelligence, to design RNA structures that can be inserted into virus genomes to increase...
This federal Project Grant award, totaling $256,500.00 and awarded on February 18, 2025 by the Department of Energy's Office of Science Financial Assistance Program (CFDA 81.049), funds the development and delivery of siRNA-containing tetrahedral RNA nanostructures into bioenergy crops using LDH-stabilized sprays. The primary recipient, Silvec Biologics, Inc., is a biotechnology company specializing in RNA interference (RNAi) technologies for agricultural applications. This grant supports Silvec...
Silvec Biologics Inc. received a $650,000 Project Grant award from the Department of Agriculture's National Institute of Food and Agriculture (CFDA 10.212 - Small Business Innovation Research (SBIR) Program / Small Business Technology Transfer (STTR) Program) to develop RNA interference (RNAi) technologies for controlling fungal diseases in agricultural crops. The company is leveraging its proprietary internally-delivered virus-like RNA (iRNA) vector system to generate small interfering RNAs...
Silvec Biologics Inc. was awarded a $174,964 Small Business Innovation Research (SBIR) Project Grant from the United States Department of Agriculture National Institute of Food and Agriculture to develop a proprietary process to control fungi using RNA interference. The SBIR program aims to support scientific innovation to build a strong national economy. Under the award, Silvec will pursue four key objectives through January 2023. The company will identify small interfering RNAs compatible with...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Multitarga LLC, a small business located in Woodbridge, CT, provides $304,995 to develop an "Adaptive Multi-Targeted Priming for Host-Pathogen Transcriptomics" technology. The goal is to enhance the sensitivity and specificity of RNA sequencing assays to better detect low-abundance pathogen transcripts in complex host-pathogen samples. The project will produce an...
This Project Grant from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems provides $500,000 to the Regents of the University of California at Riverside for research on rapid biomanufacturing of mRNA vaccines in plant chloroplasts. The award period is from January 1, 2022 to December 31, 2023. The research is funded under the NSF Directorate for Engineering's 47.041 CFDA program, which aims to improve quality of life and economic strength...
The National Science Foundation Division of Industrial Innovation awarded MBF Therapeutics Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) from January 1, 2022 to December 31, 2022. The grant funds the development of a protective T cell vaccine for SARS CoV-2 (COVID-19). The Engineering program supports innovation, creativity and excellence in engineering research and education to improve quality of life and economic strength. This award furthers those...